Use of glutamine to reduce rate of pathogenic microorganism infection
AssigneeThe Brigham and Women's Hospital, Inc.
InventorsRobert J. Smith, Douglas Wilmore
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for treating catabolic, gut-associated pathological processes including intestinal mucosal and pancreatic atrophy and enhanced gut permeability, impairment of host defenses and compromised immune function, and for promoting recovery from bone marrow transplantation in an animal, which comprises administering to an animal a therapeutically effective amount of glutamine or an analogue thereof.
Claims5
A method for reducing the rate of infection by a pathogenic microorganism, which comprises administering to an animal in need of such a treatment a therapeutically effective amount GLN in an amount greater than that present in the normal diet of said animal.
Dependencies are inferred from the claim text.